Results 51 to 60 of about 26,238 (200)

The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells

open access: yesCells, 2022
Transglutaminase 2 (TG2) is a protein expressed in many tissues that exerts numerous, sometimes contradictory, intra- and extracellular functions, under both physiological and pathophysiological conditions.
Julia Aepler   +6 more
doaj   +1 more source

Cyclotron-Based Production of 67Cu for Radionuclide Theranostics via the 70Zn(p,α)67Cu Reaction

open access: yesPharmaceuticals, 2023
Theranostic matched pairs of radionuclides have aroused interest during the last couple of years, and in that sense, copper is one element that has a lot to offer, and although 61Cu and 64Cu are slowly being established as diagnostic radionuclides for ...
Santiago Andrés Brühlmann   +6 more
doaj   +1 more source

Prospective of ⁶⁸Ga-radiopharmaceutical development

open access: yes, 2013
Positron Emission Tomography (PET) experienced accelerated development and has become an established method for medical research and clinical routine diagnostics on patient individualized basis.
Velikyan, Irina,
core   +1 more source

Tools for the Advancement of Radiopharmaceutical Therapy [PDF]

open access: yes, 2023
Radiopharmaceutical therapy is used to treat cancers and other diseases with radiolabeled pharmaceuticals. The treatment targets specific cells, and the emitted ionizing radiation cause cytotoxic damage.
Mellhammar, Emma
core  

Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review [PDF]

open access: yes, 2017
Radiopharmaceutical extravasation can potentially lead to severe soft tissue damage, but little is known about incidence, medical consequences, possible interventions, and effectiveness of these.
van der Pol, Jochem   +7 more
core   +1 more source

A Preclinical Study of an 125I-Labeled PSMA Ligand for Prostate-Cancer Puncture

open access: yes, 2022
Purpose: Prostate cancer (PCa) is characterized by high expression of prostate-specific 1membrane antigen (PSMA), a type II transmembrane protein.
Luan, Xiaohui   +17 more
core   +1 more source

KSNM60: The History of Radiopharmaceutical Sciences in Korea

open access: yes, 2022
A number of researchers in Korea have tried to set-up the production of radionuclides and develop new radiopharmaceuticals for several decades. Thanks to their 60-year endeavor to advance the field of radiopharmaceutical sciences, now we have a lot of ...
Lee, Kyo Chul   +6 more
core   +1 more source

Radiosynthesis and Preclinical Evaluation of [99mTc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections

open access: yes
Background/Objectives: As a primary source of mortality and disability, bacterial infections continue to develop a severe threat to humanity. Nuclear medicine imaging (NMI) is known for its promising potential to diagnose deep-seated bacterial infections.
Mohamed Fawzy Ramadan   +12 more
core   +1 more source

Enhanced contrast in FAP-targeting PET imaging with 61Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [61Cu]Cu-Kalios PET radioligands

open access: yesEJNMMI Radiopharmacy and Chemistry
Background Fibroblast activation protein (FAP)-targeting radioligands have gained attention for the ability to image multiple tumor types. Current FAP-targeting radioligands are labeled with 68Ga and 18F, but their short half-lives limit distribution ...
Jacopo Millul   +7 more
doaj   +1 more source

Eleventh international symposium on radiopharmaceutical chemistry [PDF]

open access: yes, 1995
This document contains abstracts of papers which were presented at the Eleventh International Symposium on Radiopharmaceutical Chemistry. Sessions included: radiopharmaceuticals for the dopaminergic system, strategies for the production and use of ...

core  

Home - About - Disclaimer - Privacy